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A phylogenetic analysis of samples taken from reported out-
breaks of peste des petits ruminants virus (PPRV) in Geor-
gia revealed a closer relationship to viruses from northern 
and eastern Africa than to viruses from countries closer to 
Georgia. This finding has crucial implications for the control 
of PPRV in the region.
Peste des petits ruminants virus (PPRV) is the cause of a highly infectious transboundary animal disease that 
affects primarily sheep, goats, and small wild ruminants. 
Death rates for PPRV in susceptible animals can be as high 
as 80% (1). Because sheep and goats contribute consid-
erably to the household and cash income and nutrition of 
small farmers in many countries, the control of PPRV is 
considered an essential element in the fight for global food 
security and poverty alleviation. For this reason, PPRV is 
being targeted by international organizations for global 
eradication by 2030 (1).
Currently, 4 genetic lineages of PPRV are circulating 
globally. The lineages are defined on the basis of sequence 
comparison of a fragment of either the nucleocapsid (N) or 
fusion (F) protein genes of the virus. PPRV lineage IV is 
found predominantly in Asia and the Middle East, whereas 
all 4 lineages have been reported in Africa (2).
During January–March 2016, outbreaks of PPRV in 
Tushuri sheep were reported in 3 farms located near Tbili-
si, the capital of Georgia. Of 3,740 susceptible sheep, 415 
(11%) showed symptoms of PPRV infection, which in-
cluded necrosis of the commissures of the lips; swelling 
and bleeding of the gums above the dental pad and buccal 
mucosa, with white cellular debris on all surfaces, includ-
ing the tongue; bronchopneumonia (in only a few animals); 
diarrhea (in 50% of lambs); and loss of appetite. Of the dis-
eased animals, 204 (49%) died, 99 (24%) were humanely 
destroyed, and the rest recovered. The outbreaks were re-
solved by the end of March 2016 (3). 
Staff of the National Food Agency in Tbilisi collected 
nasal swabs and ocular samples, which were tested in the 
laboratory of the Ministry of Agriculture in Tbilisi using 
a PPR antigen capture ELISA (IDvet, Grabels, France). 
Six positive samples were individually adsorbed onto the 
matrix of a ViveST transport tube (ViveBio Scientific, Al-
pharetta, GA, USA) and were shipped to the Institute for 
Veterinary Disease Control, Austrian Agency for Health 
and Food Safety (Mödling, Austria), for further character-
ization. A part of the same 6 samples was also shipped to 
the World Organisation for Animal Health reference labo-
ratory at the Agricultural Research Center for Internation-
al Development (Montpellier, France) for PPRV testing.
In Austria, we eluted the samples from the ViveST 
with 1 mL of Dulbecco’s modified Eagle medium high-
glucose medium and stored them at –80°C. We extracted 
total RNA from 200 µL aliquots using an RNeasy kit 
(QIAGEN, Hilden, Germany). We analyzed the extracted 
RNA samples by reverse transcription PCR (RT-PCR) using 
the One-Step RT-PCR kit (QIAGEN) to amplify fragments 
of both the PPRV N and F genes (4,5). Three of the 6 
samples tested were positive by RT-PCR (PPRV/Georgia/
G1/2016 [collected January 13, 2016], PPRV/Georgia/
G2/2016 [collected February 9, 2016], and PPRV/Georgia/
G4/2016 [collected February 9, 2016]). We purified the 
amplicons and sent them for sequencing using standard 
Sanger methods at LGC Genomics (Berlin, Germany). The 
sequences have been deposited in GenBank (accession nos. 
KY646059–64).
We constructed a phylogenetic tree of N and F gene 
segments from a representative selection of PPRV sequenc-
es available in GenBank, using the maximum-likelihood 
method available in MEGA6 (https://www.megasoftware.
net/) and employing the Kimura-2 parameter model of nu-
cleotide substitution with 1,000 bootstrap replications. The 
phylogenetic analysis revealed that the PPRVs present in 
the 3 samples from Georgia were identical and belonged 
to lineage IV (Figure). Of note, the N gene fragment se-
quences (Figure, panel A) were more related to those of 
viruses from Egypt, Eritrea, Ethiopia, and Sudan and the 
F gene fragment sequences clustered with viruses from 
Egypt, Ethiopia, and Sudan (Figure, panel B). 
Unexpectedly, the N and F gene fragment sequences 
for viruses isolated from countries close to Georgia 
(e.g., Turkey, Iran, and Iraq) were less similar to the 
Georgia viruses than to the ones from Africa. PPRV is 
a transboundary infectious disease; in many cases, new 
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outbreaks are attributable to incursion from neighboring 
countries (6–8). Therefore, a similar situation would have 
been expected for Georgia, which shares borders with 
Turkey, Armenia, and Azerbaijan in the south and Russia 
in the north. Several molecular epidemiologic studies 
of PPRV lineage IV in Turkey have been performed 
(9–11), including more than 200 N and F gene sequence 
submissions in GenBank covering a period of several 
years (1996–2015) that provide an up-to-date overview 
of the PPRVs circulating in the country. However, none of 
these sequences is similar enough to the sequences from 
Georgia to indicate a common origin (Figure). To date, 
Azerbaijan, Armenia, and Russia have not reported PPRV 
in their countries, which makes it difficult to determine 
the exact origin of the PPRV identified in Georgia. 
Because there is no obvious connection between Georgia 
and Egypt, Eritrea, Ethiopia, or Sudan through the trade 
or import of small ruminants, further work is required to 
fully clarify the PPRV situation at a regional level.
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While studying respiratory infections in Peru, we identified 
Venezuelan equine encephalitis virus (VEEV) in a nasopha-
ryngeal swab, indicating that this alphavirus can be pres-
ent in human respiratory secretions. Because VEEV may 
be infectious when aerosolized, our finding is relevant for 
the management of VEEV-infected patients and for VEEV 
transmission studies.
Venezuelan equine encephalitis virus (VEEV) is one of many alphaviruses transmitted through 
the bite of infected mosquitoes (1,2). VEEV primarily 
infects equine species, causing severe encephalitis and 
death. VEEV may also infect humans, causing fever and 
influenza-like symptoms that include headache, chills, 
myalgia, nausea, and vomiting. In severe cases, human 
VEEV infection may result in neurologic complications 
that lead to fatalities. Acute VEEV infection is usually 
confirmed by PCR, sequencing from blood (3), or 
both, or in the case of encephalitis, from spinal fluid. 
Nasopharyngeal swabs are rarely tested for alphaviruses 
like VEEV because they are considered nontraditional 
sample types for these kinds of pathogens.
The US Naval Medical Research Unit No. 6, in 
coordination with the local ministry of health, conducts 
routine surveillance for respiratory and febrile pathogens 
under Institutional Review Board–approved protocols that 
comply with all applicable federal regulations governing 
the protection of human subjects. As part of these efforts, 
nasopharyngeal swabs and serum samples are tested for 
a variety of possible etiologies. Frequently, however, a 
particular sample fails to yield a recognized etiology. This 
result happens in several scenarios: a patient is infected 
with an unknown pathogen or with a pathogen for which 
there is no known diagnostic; a known pathogen has 
mutated and changed such that a known diagnostic is no 
longer effective; or a pathogen is present at a concentration 
too low to diagnose. In these cases, it may be possible to 
identify the potential etiology using approaches that can 
identify novel or divergent pathogens, like unbiased next-
generation sequencing (NGS).
In 2013, in Iquitos, Peru, we identified a 16-year-
old boy who reported a variety of undifferentiated ill-
ness symptoms, including fever, chills, general malaise, 
myalgia, headache, rhinorrhea, sore throat, nausea, 
vomiting, abdominal pain, retroorbital pain, rash, and 
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